<p>A. On day 7 after the second immunization, the PBMC and splenocytes were prepared and immunostained with anti-CD4 mAb. The samples were stained with anti-CD4-FITC mAb and analyzed by flow cytometry. Data shown are representative of 3 independent experiments. Bar, mean and SD from 3 independent experiments, each using at least three mice per group (n = 3). For statistical analysis, mice treated with B9-23/DEX were compared with that in mice treated with B9-23 group and student-t test were used between the indicated pair; *p<0.05. B. On day 7 after the second immunization, the pancreatic samples were immunostained with anti-CD4-FITC mAb and analyzed by flow cytometry. The infiltrated lymphocytes (R1) were gated for CD4 T cells analysis. Th...
<p>(A) Thymocytes were stained with PE-conjugated anti-CD4, CyChrome-conjugated anti-CD8, and FITC-c...
<p>(A) The levels of anti-dsDNA autoantibodies in the culture supernatant from the co-cultured syste...
<p>Four doses of anti-CD8 or anti-CD4 antibody (400 µg/per mouse, i.p.) were injected at 4 day inter...
<p>A. On day 45 after the second immunization, PBMC, splenocytes and pancreas cells were immunostain...
<p>Splenocytes (2 × 10<sup>6</sup>) at 10 days post-treatment were stained with anti-CD4<sup>+</sup>...
<p>NOD mice received IDO-expressing fibroblasts upon initiation of spontaneous diabetes. At the endp...
(A) Experimental design of anti-CD4 antibody treatment in humanized mice. (B) The frequency of human...
<p>C57BL/6 mice were treated twice with 250 µg anti-CD4 Ab (GK1.5 Harlan) two and one day prior to i...
<p>At day 4 after the second treatment, the splenocytes of treated mice were prepared for intracellu...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. The freq...
<p>(A) Mice were sacrificed one day after last treatment and mononuclear cells isolated from the CNS...
<p><sup>a</sup> Number of IFNγ secreting cells/10<sup>6</sup> splenocytes (splenocytes were removed ...
<p>(A) Thymocytes were stained with PE-conjugated anti-CD4, CyChrome-conjugated anti-CD8, and FITC-c...
<p>(A) The levels of anti-dsDNA autoantibodies in the culture supernatant from the co-cultured syste...
<p>Four doses of anti-CD8 or anti-CD4 antibody (400 µg/per mouse, i.p.) were injected at 4 day inter...
<p>A. On day 45 after the second immunization, PBMC, splenocytes and pancreas cells were immunostain...
<p>Splenocytes (2 × 10<sup>6</sup>) at 10 days post-treatment were stained with anti-CD4<sup>+</sup>...
<p>NOD mice received IDO-expressing fibroblasts upon initiation of spontaneous diabetes. At the endp...
(A) Experimental design of anti-CD4 antibody treatment in humanized mice. (B) The frequency of human...
<p>C57BL/6 mice were treated twice with 250 µg anti-CD4 Ab (GK1.5 Harlan) two and one day prior to i...
<p>At day 4 after the second treatment, the splenocytes of treated mice were prepared for intracellu...
<p>(A) Flow cytometry analysis. Groups of C57BL/6 mice were injected with rat IgG, anti-CD4 or anti-...
(A-B) 106 CD45.1 OT1 T cells were transferred i.v. into CD45.2+ mice, treated with anti-CD8α or –β t...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. (B) The ...
(A) Experimental design of HIV infection and anti-CD4 antibody treatment in humanized mice. The freq...
<p>(A) Mice were sacrificed one day after last treatment and mononuclear cells isolated from the CNS...
<p><sup>a</sup> Number of IFNγ secreting cells/10<sup>6</sup> splenocytes (splenocytes were removed ...
<p>(A) Thymocytes were stained with PE-conjugated anti-CD4, CyChrome-conjugated anti-CD8, and FITC-c...
<p>(A) The levels of anti-dsDNA autoantibodies in the culture supernatant from the co-cultured syste...
<p>Four doses of anti-CD8 or anti-CD4 antibody (400 µg/per mouse, i.p.) were injected at 4 day inter...